Rocket Pharmaceuticals, Inc (RCKT) insider trading
Every open-market stock purchase and sale by Rocket Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Martin Wilson (General Counsel) and 3 others sold $432K in the last 90 days.
- Last insider buy: Elisabeth Bjork (Insider), $34.4K, 10 months ago.
Last 12 months: insiders bought $34.4K (1 buy) and sold $864K (25 sales). Last close $2.31 on Oct 22, 2026.
Recent RCKT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | Martin Wilson (General Counsel) | Sold | $256K |
| Aug 18, 2026 | Gaurav Shah (CEO) | Sold | $7.8K |
| Aug 18, 2026 | Martin Wilson (General Counsel) | Sold | $2.1K |
| Aug 13, 2026 | Martin Wilson (General Counsel) | Sold | $11.8K |
| Aug 13, 2026 | Gaurav Shah (CEO) | Sold | $9.6K |
| Aug 11, 2026 | Christopher James Stevens (COO) | Sold | $128K |
| Aug 11, 2026 | Sarbani Chaudhuri (Insider) | Sold | $16.4K |
| Aug 3, 2026 | Christopher James Stevens (COO) | Bought (not open market) | — |
| Aug 3, 2026 | David P Southwell (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Christopher James Stevens (COO) | Bought (not open market) | — |
| Jun 18, 2026 | Carsten Boess (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Carsten Boess (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Fady Ibraham Malik (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Peter Fong (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Roderick Wong (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Roderick Wong (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Peter Fong (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Mikael Dolsten (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Mikael Dolsten (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | Fady Ibraham Malik (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | David P Southwell (Insider) | Bought (not open market) | — |
| Jun 18, 2026 | David P Southwell (Insider) | Bought (not open market) | — |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $1.1M |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $998K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $737K |
Who's trading RCKT
- Martin Wilson, General Counsel: sold $335K (8 sales), last Sep 11, 2026
- Gaurav Shah, CEO: sold $286K (8 sales), last Aug 18, 2026
- Christopher James Stevens, COO: sold $128K (1 sale), last Aug 11, 2026
- Sarbani Chaudhuri, Insider: sold $84.2K (2 sales), last Aug 11, 2026
- David P Southwell, Insider: other filings, last Aug 3, 2026
- Peter Fong, Insider: other filings, last Jun 18, 2026
- Mikael Dolsten, Insider: other filings, last Jun 18, 2026
- Fady Ibraham Malik, Insider: other filings, last Jun 18, 2026
- Roderick Wong, Insider: other filings, last Jun 18, 2026
- Carsten Boess, Insider: other filings, last Jun 18, 2026
- John Militello, Insider: sold $23.7K (5 sales), last May 26, 2026
- Syed Ali-aamir Rizvi, C-suite exec: other filings, last Feb 11, 2026
- Elisabeth Bjork, Insider: bought $34.4K (1 buy), last Jan 2, 2026
- Jonathan David Schwartz, Insider: sold $7.6K (1 sale), last Nov 18, 2025
Get free alerts when an insider at Rocket Pharmaceuticals, Inc files a new trade →